Epigenetische Veränderungen programmieren Astrozyten zu Hirnstammzellen um
Ruhende Hirnstammzellen unterscheiden sich kaum von normalen Astrozyten, die im Gehirn die Nervenzellen unterstützen. Wi…
Roche NimbleGen Introduces Advanced RNA-Seq Target Enrichment Tools for In-Depth Transcriptome Studies
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
Priority Programme "Chemical Biology of Native Nucleic Acid Modifications" (SPP 1784)
The Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced the establishment of…
Roche NimbleGen Introduces Novel NGS Target Enrichment Solution for Methylation Assessment
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation a…
GATC Biotech conducts research to detect cancer in women
After successfully launching the PraenaTest of its subsidiary LifeCodexx, Europe's leading service provider of DNA-seque…
High-Resolution Melting Analysis Using the Roche LightCycler Instrument for Rapid and Reliable Methylation Detection in Archival Tissue Samples
Promoter hypermethylation is a frequent mechanism for the repression of gene transcription in cancer and is regarded as…
Epigenomics AG Launches Diagnostic Lung Cancer Test in Europe
. - The Epi proLung BL Reflex Assay complements conventional diagnostic methods - Test may identify cancers otherwise…
Epigenomics und TIB MOLBIOL: Markteinführung neuer Produktserie auf Analytica 2008
Epigenomics AG (Frankfurt, Prime Standard: ECX), ein molekulardiagnostisches Unternehmen, das Krebstests auf der Basis…
Epigenomics AG gibt Ergebnisse des ersten Quartals 2006 bekannt
Das Molekulardiagnostik-Unternehmen Epigenomics AG (Frankfurt, Prime Standard: ECX), das Tests basierend auf DNA-Methyli…
QIAGEN Eliminates Key Bottleneck in Epigenetic Research
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the…